Compounded semaglutide is widely used for chronic weight management in adults who are overweight or obese, even without diabetes, as long as they meet the clinical criteria and have no contraindications
Tirzepatide and Liraglutide microdosing Similar to semaglutide microdosing, tirzepatide microdosing is an off-label practice of taking a weekly dose of tirzepatide (brand names Mounjaro or Zepbound) that is lower than the FDA-approved 2.5 mg starting dose to reduce common gastrointestinal side effects and potentially lower the cost by making the medication last longer
Though the absolute risk appears to be small, more study is warranted to confirm whether GLP-1s can negatively affect some peoples sense of smell and taste, the researchers say
You can ask the compounding pharmacist where their semaglutide is sourced from and check the FDAs online database to confirm whether the facility is registered and inspected
Combining these drugs is not recommended and could increase the risk of side effects, some of which could be serious
The first was a review looking at the therapeutic potential of butyrate in treating type 2 diabetes